Please provide your email address to receive an email when new articles are posted on . Participants in the supplement group had better Schirmer’s test scores and improvement in OSDI scores vs. the ...
Change from baseline at day 56 (week eight) in tear production (Schirmer’s test). Change from baseline at day 56 in ocular symptoms measured by OSDI score. The study also met secondary endpoints, ...
Reproxalap significantly reduced ocular redness and increased tear production in DED patients compared to placebo, achieving primary and secondary endpoints. The study involved 57 participants with ...
Please provide your email address to receive an email when new articles are posted on . Botulinum toxin A significantly improved tear breakup time, tear meniscus height and Schirmer test score.
Scientists have produced an organoid model of the human conjunctiva. These organoids mimic the function of the actual human conjunctiva, a tissue involved in tear production. Using their new model, ...
Severe, chronic dry eye or dry eye disease (DED) can persist for a long time and may resist standard treatments. It can happen when tear production is low or when tear flow is blocked. Severe dry eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results